Why Is Eysuvis So Hard to Find? [Explained for 2026]

If you've been prescribed Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%) and found it missing from your pharmacy's shelf, you're not alone. Despite being FDA-approved and manufactured by a major company, Eysuvis can be genuinely difficult to locate at pharmacies across the country. In this post, we'll explain exactly why — and what you can do about it.

What Is Eysuvis and Why Does It Matter?

Eysuvis is a prescription corticosteroid eye drop indicated for the short-term treatment — up to two weeks — of the signs and symptoms of dry eye disease. It was FDA-approved in October 2020 and became commercially available in January 2021 as the first and only prescription corticosteroid specifically approved for dry eye disease flares.

It works by reducing inflammation in the eyes caused by dry eye. What makes Eysuvis different from older steroid eye drops is its use of AMPPLIFY mucus-penetrating particle (MPP) drug delivery technology, which helps the loteprednol penetrate the mucus layer on the eye's surface more effectively. The result is rapid symptom relief — clinical trials showed significant reduction in ocular discomfort as early as Day 4.

Is There an Official Eysuvis Shortage?

As of 2026, Eysuvis is not listed on the FDA's official Drug Shortage Database. There is no manufacturer-declared, FDA-tracked shortage of Eysuvis. However, just because there's no official shortage doesn't mean the drug is easy to find at your local pharmacy. Many patients experience what's often called a "practical shortage" — the drug exists and is being manufactured, but their specific pharmacy doesn't carry it.

Why Is Eysuvis Hard to Find at Pharmacies?

There are several interconnected reasons why Eysuvis may not be on the shelf when you need it:

1. There Is No Generic Version of Eysuvis

As of 2026, Eysuvis is only available as a brand-name medication. There is no FDA-approved generic equivalent. This is important because pharmacies tend to stock and promote generics over brand-name drugs — they're cheaper for the pharmacy to purchase and for patients to buy. Without a cheaper generic option to push demand, many chain pharmacies simply don't maintain regular Eysuvis inventory.

2. Eysuvis Is a Niche, Short-Term Medication

Unlike chronic dry eye medications like Restasis or Xiidra that patients take indefinitely, Eysuvis is prescribed only for short courses — up to two weeks. This means each patient only needs one bottle, and many patients won't need a refill for months or years. Lower prescription volumes make it a lower priority for pharmacies when making stocking decisions.

3. Insurance Coverage Is Inconsistent

Many insurance plans place Eysuvis on Tier 3 or Tier 4 of their formulary, making the copay higher than many patients expect. Some plans require prior authorization, and others require step therapy — you must try and fail cheaper alternatives like over-the-counter artificial tears before they'll approve Eysuvis. When patients can't get coverage, they may abandon their prescription. Pharmacies notice this and reduce inventory.

4. Specialty Pharmacies May Stock It More Reliably

Big-box chain pharmacies are not always the best place to find specialty ophthalmic medications like Eysuvis. Independent pharmacies and pharmacies that work closely with ophthalmology practices often have more reliable stock because their customer base actually uses these medications. If your local CVS or Walgreens is out, try calling independent pharmacies or a pharmacy near an eye care clinic.

5. The Retail Price Is High Without Assistance Programs

The average retail cash price for Eysuvis is approximately $529 to $687 for a single 8.3 mL bottle. That's a significant cost barrier, and many patients abandon their prescription when they see the price at the pharmacy counter. Fortunately, the Alcon Patient Access Program offers copay assistance — commercially insured patients can pay as little as $30, and those without coverage may qualify for $79 per prescription. Patient assistance programs also exist for those who qualify financially.

What Can You Do If Your Pharmacy Doesn't Have Eysuvis?

Here are practical steps you can take right now:

Ask your pharmacist to order it — most pharmacies can get brand-name medications within 1-2 business days if they don't carry it in stock.

Call ahead before transferring your prescription — don't assume a pharmacy has it just because they accept your insurance.

Try specialty or independent pharmacies near ophthalmology clinics — they often stock ophthalmic medications more reliably.

Use medfinder — medfinder calls local pharmacies on your behalf to check which ones have Eysuvis in stock, then texts you the results. No more calling around yourself.

Use mail-order pharmacy — some insurance plans allow or even require 90-day supplies via mail order, which can guarantee delivery.

What If You Still Can't Get Eysuvis?

If you're facing a prolonged delay, talk to your eye doctor about bridging options. There are several other prescription dry eye treatments available, including Restasis (cyclosporine), Xiidra (lifitegrast), and Miebo (perfluorohexyloctane). Each works differently from Eysuvis. See our guide to alternatives to Eysuvis for a detailed comparison.

Your ophthalmologist or optometrist may also have sample bottles on hand for patients who are between fills or waiting for a pharmacy to get the medication in stock. It's always worth asking.

The Bottom Line

Eysuvis isn't in an official FDA shortage, but its brand-only status, niche indication, high retail price, and inconsistent insurance coverage all contribute to real-world availability challenges. The good news is that with the right tools and strategies, most patients can get their prescription filled. For more actionable tips, read our guide on how to find Eysuvis in stock near you.